Literature DB >> 1428185

Rapidly fatal Q-fever pneumonia in a patient with chronic granulomatous disease.

J F Meis1, C R Weemaes, A M Horrevorts, S J Aerdts, P J Westenend, J M Galama.   

Abstract

Acute Q-fever is a systemic illness which rarely has a fatal outcome. Fatal cases do occur with the chronic form of the disease and associated with endocarditis. This report presents the case of a fatal, acute Q-fever pneumonia in an 11-year-old patient with chronic granulomatous disease. Complement fixation antibody titer rose to 1:1,024 with positive IgM in immunofluorescence. Giemsa stained lung sections and indirect immunofluorescence demonstrated the microorganisms in the tissues. The Coxiella burnetii infection was probably contracted during a holiday trip to rural France. Despite the fact that the patient received a variety of antimicrobial agents with broad spectrum activity against bacteria and fungi, coverage for Q-fever, i.e. chloramphenicol or tetracyclines, was not included.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1428185     DOI: 10.1007/bf01710798

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  11 in total

1.  The pathologic findings in rickettsial pneumonia.

Authors:  F P Urso
Journal:  Am J Clin Pathol       Date:  1975-09       Impact factor: 2.493

2.  Acute and chronic Q fever in patients with cancer.

Authors:  D Raoult; P Brouqui; B Marchou; J A Gastaut
Journal:  Clin Infect Dis       Date:  1992-01       Impact factor: 9.079

3.  Incidence, severity, and prevention of infections in chronic granulomatous disease.

Authors:  R Mouy; A Fischer; E Vilmer; R Seger; C Griscelli
Journal:  J Pediatr       Date:  1989-04       Impact factor: 4.406

4.  Q fever endocarditis in the south of France.

Authors:  D Raoult; J Etienne; P Massip; S Iaocono; M A Prince; P Beaurain; S Benichou; J C Auvergnat; P Mathieu; P Bachet
Journal:  J Infect Dis       Date:  1987-03       Impact factor: 5.226

5.  Leukocyte transfusions in chronic granulomatous disease: persistence of transfused leukocytes in sputum.

Authors:  E S Buescher; J I Gallin
Journal:  N Engl J Med       Date:  1982-09-23       Impact factor: 91.245

6.  [Q fever in the Netherlands; a description of 33 case reports observed between 1979 and 1983].

Authors:  J H Richardus; G J Schaap; A Donkers; A M Dumas; J Huisman
Journal:  Ned Tijdschr Geneeskd       Date:  1984-12-01

7.  Coxiella burnetii infection in immunocompromised patients.

Authors:  S R Heard; C J Ronalds; R B Heath
Journal:  J Infect       Date:  1985-07       Impact factor: 6.072

Review 8.  Q fever: current concepts.

Authors:  L A Sawyer; D B Fishbein; J E McDade
Journal:  Rev Infect Dis       Date:  1987 Sep-Oct

9.  Genetic variants of chronic granulomatous disease: prevalence of deficiencies of two cytosolic components of the NADPH oxidase system.

Authors:  R A Clark; H L Malech; J I Gallin; H Nunoi; B D Volpp; D W Pearson; W M Nauseef; J T Curnutte
Journal:  N Engl J Med       Date:  1989-09-07       Impact factor: 91.245

10.  Erythromycin and the treatment of Coxiella burnetii pneumonia.

Authors:  A Pérez-del-Molino; J M Aguado; J A Riancho; I Sampedro; P Matorras; J Gonzalez-Macias
Journal:  J Antimicrob Chemother       Date:  1991-09       Impact factor: 5.790

View more
  2 in total

Review 1.  Emerging Infections and Pertinent Infections Related to Travel for Patients with Primary Immunodeficiencies.

Authors:  Kathleen E Sullivan; Hamid Bassiri; Ahmed A Bousfiha; Beatriz T Costa-Carvalho; Alexandra F Freeman; David Hagin; Yu L Lau; Michail S Lionakis; Ileana Moreira; Jorge A Pinto; M Isabel de Moraes-Pinto; Amit Rawat; Shereen M Reda; Saul Oswaldo Lugo Reyes; Mikko Seppänen; Mimi L K Tang
Journal:  J Clin Immunol       Date:  2017-08-07       Impact factor: 8.317

2.  Chronic granulomatous disease: a review of the infectious and inflammatory complications.

Authors:  Eunkyung Song; Gayatri Bala Jaishankar; Hana Saleh; Warit Jithpratuck; Ryan Sahni; Guha Krishnaswamy
Journal:  Clin Mol Allergy       Date:  2011-05-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.